BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

The Center For Business Intelligence Announces Domestic Outsourcing For Drug Discovery Conference


10/19/2005 5:12:21 PM

WOBURN, Mass., Dec. 2 /PRNewswire/ -- The Center for Business Intelligence announces Domestic Outsourcing for Drug Discovery Conference, co-sponsored by The Wall Street Journal.

The Center for Business Intelligence (CBI) will hold Domestic Outsourcing for Drug Discovery on January 27-28, 2005 at Marriott San Diego in San Diego, CA.

While in the past pharmaceutical and biotech companies have been hesitant to send the drug discovery process out of house, the escalating costs of drug development, the complexity of discovery research and an increasing pressure to speed up the rate of new product launches have led to an increasing trend towards outsourcing drug discovery.

The conference focuses on the discovery outsourcing options that are available both through vendors, whose business model is purely contract work, and via partnering and licensing options. Industry perspectives on "Why They Outsource" are provided by Arena Pharmaceuticals, Chiron, Genentech, Novartis Pharmaceutical Corp, Purdue Pharma L.P. and Targacept, Inc.

Join colleagues at this conference in learning about the many benefits an outsourcing provider or partner can offer.

   -- Access to the latest technology without an ongoing commitment to the
   full costs and risks or an internal, up-front investment
   -- Highly effective genomics and proteomics technology to enhance the
   ability to find more and better targets
   -- Discovery chemistry technologies, including combi-chem, compu-chem,
   purification and characterization, to enable thorough lead generation
   -- Early evaluation of drug metabolism profile and drug interaction
   potential
   -- Combined rapid design and synthesis of focused libraries to increase
   the speed of development of hits to leads and subsequent medicinal
   chemistry optimization
   -- Gram quantities of lead compounds for smaller companies with little or
   no synthesis capabilities

Executive Sponsors are: Ricerca Biosciences, Naeja, Discovery Partners with outstanding support provide by: Pharma IT, American Pharmaceutical Outsourcing, PharmSource, CanBiotech and Bio/Pharmaceutical Outsourcing Report.

CBI events provide real life case examples given by leading experts and are excellent environments for networking. We look forward to seeing you on January 27-28, 2005 in San Diego, CA.

For more information on this event or to register, contact CBI Registration at 800-817-8601 Fax 781-939-2490 Email cbireg@cbinet.com. Please visit us online at http://www.cbinet.com/events/HB513/index.html

CBI Research Inc.

CONTACT: CBI Registration at +1-800-817-8601, Fax +1-781-939-2490,cbireg@cbinet.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES